Evidence map›Paper›PMID 35968189›Full record

ArticleJournal of oral and maxillofacial pathology : JOMFP

Anti-fibrotic activity of licorice extract in comparison with colchicine on areca nut-induced fibroblasts: An

Amritha James, Nandhini Gunasekaran, Rajkumar Krishnan, Preethi Arunachalam, Ramya Mahalingam

Open access · hybridAbstract read
In one paragraph

Article in Journal of oral and maxillofacial pathology : JOMFP. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
1.1field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 7 citations in OpenAlex.

  1. Review
  2. The Power of Licorice (Healthcare (Basel, Switzerland) · 2023
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Amritha JamesDepartment of Oral Pathology and Microbiology, SRM Dental College, Chennai, Tamil Nadu, India.
Nandhini GunasekaranDepartment of Oral Pathology and Microbiology, SRM Dental College, Chennai, Tamil Nadu, India.
Rajkumar KrishnanDepartment of Oral Pathology and Microbiology, SRM Dental College, Chennai, Tamil Nadu, India.
Preethi ArunachalamDepartment of Oral Pathology and Microbiology, SRM Dental College, Chennai, Tamil Nadu, India.
Ramya MahalingamDepartment of Oral Pathology and Microbiology, SRM Dental College, Chennai, Tamil Nadu, India.
SRM Dental College · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: Oral submucous fibrosis (OSMF) is a debilitating chronic disease of the oral cavity with a high potential for malignant transformation. The main etiological agent attributed to the development of OSMF is the use of smokeless tobacco products like areca nut. There is no known cure for the disease. Current modalities of treatment do not provide a complete cure and often prove invasive for the patient. Herbal preparations using natural compounds and medicinal plant extracts have long since been used in India, as an acceptable, noninvasive and cost-effective method in the treatment of various diseases. Hence, the present study aims to assess the anti-fibrotic effect of licorice in comparison with colchicine on areca nut-induced fibroblasts. Materials and Methods: Extracts of areca nut, licorice and colchicine were prepared in accordance with established protocols. Human fibroblast cell lines were procured from ATCC Results: Collagen accumulation decreased with increase in the concentration of licorice extract with maximum reduction seen at 200 μg/ml. Kruskal-Wallis test was done to analyze the difference in collagen accumulation. Analysis revealed that the Conclusion: The current study proves the antifibrotic efficacy of licorice in areca nut induced cell lines and hence, this agent can be used for the therapeutic management of OSMF.

Indexed as

Colchicinelicoricemalignant transformationoral submucous fibrosisphytochemical therapies

Identifiers

PMID35968189
PMCPMC9364645
OpenAlexW4298862866

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.